Summary
The publisher, an industry analysis specialist, has released its latest report, “Argentina Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Argentina. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Argentina. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.
Argentina is the third-largest pharmaceutical market in Latin America after Brazil and Mexico, with a strong focus on healthcare reforms and R&D. Argentina's health care system is composed of a universal health care system and a private system. Argentina’s pharmaceutical market increased from $4.92B in 2011 to $6.12B in 2017 at a Compound Annual Growth Rate (CAGR) of 3.7%. Argentina’s medical devices market was valued at $1.57B in 2015, which increased at a CAGR of 3.4% to reach $1.78B in 2019. Argentina’s pharmaceutical market is driven by the presence of domestic laboratories, the growing prevalence of non-communicable diseases, and favorable clinical trial regulations. In December 2019, Law No. 27,541 was established to focus on public emergency and protection of healthcare personnel during the COVID-19 Pandemic. Along with Article 76, Law 27,541 delegates important legislative powers to Argentina Executive (PEN) to strengthen the MOH.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Argentina, and includes -
Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
The publisher, an industry analysis specialist, has released its latest report, “Argentina Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Argentina. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Argentina. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.
Argentina is the third-largest pharmaceutical market in Latin America after Brazil and Mexico, with a strong focus on healthcare reforms and R&D. Argentina's health care system is composed of a universal health care system and a private system. Argentina’s pharmaceutical market increased from $4.92B in 2011 to $6.12B in 2017 at a Compound Annual Growth Rate (CAGR) of 3.7%. Argentina’s medical devices market was valued at $1.57B in 2015, which increased at a CAGR of 3.4% to reach $1.78B in 2019. Argentina’s pharmaceutical market is driven by the presence of domestic laboratories, the growing prevalence of non-communicable diseases, and favorable clinical trial regulations. In December 2019, Law No. 27,541 was established to focus on public emergency and protection of healthcare personnel during the COVID-19 Pandemic. Along with Article 76, Law 27,541 delegates important legislative powers to Argentina Executive (PEN) to strengthen the MOH.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Argentina, and includes -
- An overview of the pharmaceutical markets, comprising market size, segmentation, COVID-19 epidemiology and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Novartis, Bago, Bayer, and Roemmers)
- Profiles and SWOT analyses of the major players in the medical device market (Essilor, Siemens, DePuy Synthes, Sonova, and GN Hearing)
- Detailed analysis about recent completed deals in the pharmaceutical market of Argentina
- Information regarding the health-tech landscape of the country along with the major health-tech deals-
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Argentina healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Argentina healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analysing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Argentina healthcare market
Table of Contents
1 Table of Contents
2 Executive Summary
3 Overview of Pharmaceutical Market
4 Overview of Medical Device Market
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
6 Deal analysis
7 HealthTech Landscape
8 Market Access
9 Country Healthcare Landscape
13 Appendix
List of Tables
List of Figures
